Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Bildat

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 18, 2000
Combined modality therapy in NSCLCW Eberhardt, S Bildat, S Korfee
Lung Cancer (Amsterdam, Netherlands)|September 29, 2001
Preoperative treatment strategies in stage III non-small cell lung cancerW Eberhardt, S Bildat, S Korfee, et al.
The Annals of Thoracic Surgery|October 30, 1999
Preoperative chemoradiotherapy and surgery for selected non-small cell lung cancer IIIB subgroups: long-term resultsG Stamatis, W Eberhardt, G Stüben, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 9, 2002
Induction chemotherapy followed by concurrent chemotherapy and definitive high-dose radiotherapy for patients with locally advanced non-small-cell lung cancer (stages IIIa/IIIb): a pilot phase I/II trialC Pöttgen, W Eberhardt, S Bildat, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2001
Phase ii comparator study of oral versus intravenous topotecan in patients with chemosensitive small-cell lung cancerJ von Pawel, U Gatzemeier, J L Pujol, et al.
Leukemia|August 15, 2017
Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinantsR Hehlmann, M Lauseker, S Saußele, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 18, 2000
Combined modality therapy in NSCLCW Eberhardt, S Bildat, S Korfee
Lung Cancer (Amsterdam, Netherlands)|September 29, 2001
Preoperative treatment strategies in stage III non-small cell lung cancerW Eberhardt, S Bildat, S Korfee, et al.
The Annals of Thoracic Surgery|October 30, 1999
Preoperative chemoradiotherapy and surgery for selected non-small cell lung cancer IIIB subgroups: long-term resultsG Stamatis, W Eberhardt, G Stüben, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 9, 2002
Induction chemotherapy followed by concurrent chemotherapy and definitive high-dose radiotherapy for patients with locally advanced non-small-cell lung cancer (stages IIIa/IIIb): a pilot phase I/II trialC Pöttgen, W Eberhardt, S Bildat, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2001
Phase ii comparator study of oral versus intravenous topotecan in patients with chemosensitive small-cell lung cancerJ von Pawel, U Gatzemeier, J L Pujol, et al.
Leukemia|August 15, 2017
Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinantsR Hehlmann, M Lauseker, S Saußele, et al.
Pageof 1